Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

被引:416
作者
Videla, LA
Rodrigo, R
Orellana, M
Fernandez, V
Tapia, G
Quiñones, L
Varela, N
Contreras, J
Lazarte, R
Csendes, A
Rojas, J
Maluenda, F
Burdiles, P
Diaz, JC
Smok, G
Thielemann, L
Poniachik, J
机构
[1] Univ Chile, Mol & Clin Pharmacol Program, Inst Biomed Sci, Fac Med, Santiago 7, Chile
[2] Univ Chile, Clin Hosp, Dept Med, Santiago 7, Chile
[3] Univ Chile, Clin Hosp, Dept Surg, Santiago 7, Chile
[4] Univ Chile, Clin Hosp, Dept Pathol Anat, Santiago 7, Chile
[5] Univ Chile, Fac Med, Pathophysiol Program, Inst Biomed Sci, Santiago 7, Chile
关键词
non-alcoholic fatty liver disease; oxidative stress; steatohepatitis; steatosis;
D O I
10.1042/CS20030285
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oxidative stress is implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). In the present study, hepatic and plasma oxidative stress-related parameters were measured and correlated with clinical and histological findings in 31 NAFLD patients showing increased body mass index. Liver protein carbonyl content was enhanced by 403 % in patients with steatosis (n = 15) compared with control values (n = 12), whereas glutathione content, superoxide dismutase (SOD) activity and the ferric reducing ability of plasma (FRAP) were decreased by 57 %, 48 % and 2 1 % (P < 0.05) respectively. No changes in microsomal p-nitrophenol hydroxylation and the total content of cytochrome P450 (CYP) or CYP2EI were observed. Patients with steatohepatitis (n = 16) exhibited protein carbonyl content comparable with that of controls, whereas glutathione content, SOD and catalase activities were decreased by 27%, 64% and 48% (P<0.05). In addition, FRAP values in patients with steatohepatitis were reduced by 33 % and 15 % (P < 0.05) when compared with controls and patients with steatosis respectively, whereas p-nitrophenol hydroxylation (52 %) and CYP2EI content (142 %) were significantly increased (P < 0.05) compared with controls. It is concluded that oxidative stress is developed in the liver of NAFLD patients with steatosis and is exacerbated further in patients with steatohepatitis, which is associated with CYP2EI induction. Substantial protein oxidation is followed by proteolysis of the modified proteins, which may explain the co-existence of a diminished antioxidant capacity and protein oxidation in the liver of patients with steatohepatitis.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [41] Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease-Oxidative Stress and Inflammation Relevance
    Robea, Madalina Andreea
    Balmus, Ioana-Miruna
    Girleanu, Irina
    Huiban, Laura
    Muzica, Cristina
    Ciobica, Alin
    Stanciu, Carol
    Cimpoesu, Carmen Diana
    Trifan, Anca
    MEDICINA-LITHUANIA, 2023, 59 (09):
  • [42] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [43] Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Ramai, Daryl
    Facciorusso, Antonio
    Vigandt, Erika
    Schaf, Bryan
    Saadedeen, Waleed
    Chauhan, Aditya
    di Nunzio, Sara
    Shah, Aashni
    Giacomelli, Luca
    Sacco, Rodolfo
    CELLS, 2021, 10 (12)
  • [44] Procoagulant imbalance in patients with non-alcoholic fatty liver disease
    Tripodi, Armando
    Fracanzani, Anna L.
    Primignani, Massimo
    Chantarangkul, Veena
    Clerici, Marigrazia
    Mannucci, Pier Mannuccio
    Peyvandi, Flora
    Bertelli, Cristina
    Valenti, Luca
    Fargion, Silvia
    JOURNAL OF HEPATOLOGY, 2014, 61 (01) : 148 - 154
  • [45] PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE
    Delvin, Edgard
    Patey, Natasha
    Dubois, Josee
    Henderson, Melanie
    Levy, Emile
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2015, 34 (01) : 3 - 12
  • [46] Histopathology of Non-Alcoholic Fatty Liver Disease
    Brunt, Elizabeth M.
    CLINICS IN LIVER DISEASE, 2009, 13 (04) : 533 - +
  • [47] Carotenoids and non-alcoholic fatty liver disease
    Yilmaz, Bahiddin
    Sahin, Kazim
    Bilen, Hande
    Bahcecioglu, Ibrahim H.
    Bilir, Birdal
    Ashraf, Sara
    Halazun, Karim J.
    Kucuk, Omer
    HEPATOBILIARY SURGERY AND NUTRITION, 2015, 4 (03) : 161 - 171
  • [48] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6
  • [49] Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
    Yan, Hong-Mei
    Xia, Ming-Feng
    Wang, Yan
    Chang, Xin-Xia
    Yao, Xiu-Zhong
    Rao, Sheng-Xiang
    Zeng, Meng-Su
    Tu, Yin-Fang
    Feng, Ru
    Jia, Wei-Ping
    Liu, Jun
    Deng, Wei
    Jiang, Jian-Dong
    Gao, Xin
    PLOS ONE, 2015, 10 (08):
  • [50] An update on non-alcoholic fatty liver disease
    Méndez-Sánchez, N
    Chávez-Tapia, NC
    Uribe, M
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2004, 56 (01): : 72 - 82